The 2nd International Standard for Fibrinogen Concentrate, consists of ampoules, coded 09/242, containing aliquots of a freeze-dried concentrate of fibrinogen prepared from human plasma. This preparation was established by the Expert Committee on Biological Standardization of the World Health Organization in October 2012, with labelled contents for Clottable Protein and Total Protein. Details of the preparation and value assignment are available in the document WHO/BS/2012.2208,(available from WHO). This standard is primarily intended to be used to calibrate secondary and/or in-house working fibrinogen concentrate standards.
This preparation is not for administration to humans or animals in the human food chain. WHO09/242
The preparation contains material of human origin, and either the final product or the source materials, from which it is derived, have been tested and found negative for HBsAg, anti-HIV and HCV RNA. As with all materials of biological origin, this preparation should be regarded as potentially hazardous to health. It should be used and discarded according to your own laboratory’s safety procedures. Such safety procedures should include the wearing of protective gloves and avoiding the generation of aerosols. Care should be exercised in opening ampoules or vials, to avoid cuts. 可溯源纤维蛋白原B国际标准物质